Source comparison
BPC-157 vs GHK-Cu FAQs
BPC-157 is a gastric pentadecapeptide primarily studied for internal tissue repair — gut healing, tendon recovery, and ligament support. GHK-Cu is a copper tripeptide focused on skin regeneration, collagen synthesis, and cosmetic tissue remodeling. They target
This comparison does not assign a generated winner or score.
- BPC-157 is a gastric pentadecapeptide primarily studied for internal tissue repair — gut healing, tendon recovery, and ligament support. GHK-Cu is a copper tripeptide focused on skin regeneration, collagen synthesis, and cosmetic tissue remodeling. They target fundamentally different tissue systems despite both being regenerative.
- GHK-Cu has significantly more research supporting skin applications. It directly stimulates collagen and elastin synthesis, promotes dermal remodeling, and is available in topical formulations. BPC-157 has some wound healing data but is not primarily a skin-focused peptide in preclinical research.
- BPC-157 has far more preclinical evidence for internal tissue repair. It has been studied extensively in gut ulcer, inflammatory bowel, tendon, and ligament injury models. GHK-Cu research focuses almost entirely on skin, wound surface healing, and cosmetic applications rather than internal organs.
- Yes, they appear together in stacks like the Glow stack, where BPC-157 handles internal tissue support and GHK-Cu targets skin and collagen pathways. Their mechanisms do not overlap, making them complementary in regenerative research protocols. No human trials have evaluated the combination.